1019 related articles for article (PubMed ID: 18929228)
21. Antihypertensive strategy based on angiotensin II receptor blockers: a new gateway to reduce risk in hypertension.
Tocci G; Sciarretta S; Facciolo C; Volpe M
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):767-76. PubMed ID: 17605654
[TBL] [Abstract][Full Text] [Related]
22. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
Lim S
Acta Med Indones; 2008 Jan; 40(1):34-7. PubMed ID: 19054878
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II receptor blockers in the treatment of the cardiovascular disease continuum.
Chrysant SG
Clin Ther; 2008; 30 Pt 2():2181-90. PubMed ID: 19281913
[TBL] [Abstract][Full Text] [Related]
24. Progression of cardiovascular damage: the role of renin-angiotensin system blockade.
Probstfield JL; O'Brien KD
Am J Cardiol; 2010 Jan; 105(1 Suppl):10A-20A. PubMed ID: 20102969
[TBL] [Abstract][Full Text] [Related]
25. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
de Zeeuw D
Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
[TBL] [Abstract][Full Text] [Related]
26. [Renin-angiotensin system modulation: instructions for use].
Bellis A; Rozza F; Crispo S; Trimarco B
G Ital Cardiol (Rome); 2008 Feb; 9(2):79-89. PubMed ID: 18383770
[TBL] [Abstract][Full Text] [Related]
27. Clinical evidence for the cardiovascular benefits of angiotensin receptor blockers.
Nickenig G; Ostergren J; Struijker-Boudier H
J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7 Suppl 1():S1-7. PubMed ID: 16969748
[TBL] [Abstract][Full Text] [Related]
28. Anti-diabetic effect of blockade of the renin-angiotensin system.
Ando K; Fujita T
Diabetes Obes Metab; 2006 Jul; 8(4):396-403. PubMed ID: 16776746
[TBL] [Abstract][Full Text] [Related]
29. Renin-angiotensin system modulation for treatment and prevention of cardiovascular diseases: toward an optimal therapeutic strategy.
Giles TD
Rev Cardiovasc Med; 2007; 8 Suppl 2():S14-21. PubMed ID: 17401312
[TBL] [Abstract][Full Text] [Related]
30. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
Boucek P
Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
[TBL] [Abstract][Full Text] [Related]
31. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.
Parving HH; Brenner BM; McMurray JJ; de Zeeuw D; Haffner SM; Solomon SD; Chaturvedi N; Ghadanfar M; Weissbach N; Xiang Z; Armbrecht J; Pfeffer MA
Nephrol Dial Transplant; 2009 May; 24(5):1663-71. PubMed ID: 19145003
[TBL] [Abstract][Full Text] [Related]
32. The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function.
Qian C; Schoemaker RG; van Gilst WH; Roks AJ
Clin Sci (Lond); 2009 Feb; 116(4):301-14. PubMed ID: 19138171
[TBL] [Abstract][Full Text] [Related]
33. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials.
Abuissa H; Jones PG; Marso SP; O'Keefe JH
J Am Coll Cardiol; 2005 Sep; 46(5):821-6. PubMed ID: 16139131
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.
Epstein BJ; Gums JG
Ann Pharmacother; 2005 Mar; 39(3):470-80. PubMed ID: 15701766
[TBL] [Abstract][Full Text] [Related]
36. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
[TBL] [Abstract][Full Text] [Related]
37. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.
Onuigbo MA
Hemodial Int; 2009 Oct; 13 Suppl 1():S24-9. PubMed ID: 19775421
[TBL] [Abstract][Full Text] [Related]
38. Renin-Angiotensin-Aldosterone system inhibition in prevention of diabetes mellitus.
Bălută M; Vintilă V; Vintilă M
Rom J Intern Med; 2004; 42(2):277-88. PubMed ID: 15529618
[TBL] [Abstract][Full Text] [Related]
39. [How I treat... by optimizing the blockade of the renin-angiotensin-aldosterone system].
Schleich F; Krzesinski JM; Piérard L; Scheen AJ
Rev Med Liege; 2008 Apr; 63(4):174-81. PubMed ID: 18575070
[TBL] [Abstract][Full Text] [Related]
40. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
Azizi M; Ménard J
Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
